跳至主要内容
临床试验/NCT00522522
NCT00522522已完成不适用

Naturalistic Study to Evaluate the Utilization of Care Services Associated to the Diagnostic Process of Any Kind of Epilepsy Until Being Confirmed (EPILIVE Study)

UCB Pharma1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2008年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
UCB Pharma
入组人数
400
试验地点
1

研究概览

简要总结

Naturalistic, multicentre, epidemiological study to evaluate the care services used during the process of diagnosis of any kind of epilepsy. Data about services since first seizure until confirmed diagnosis will be examined.

研究设计

研究类型
Observational
时间视角
Retrospective

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients of both sexes 16 years old or older, being diagnosed of any kind of EPILEPSY (criteria ILAE) and with diagnosis being confirmed by a Neurologist over the last 6 months and with write informed consent.

排除标准

  • Patients with epilepsy diagnosis confirmed by a Neurologist over the last 6 months before the study or with incapacity to fulfill the requirements of the study.

研究者

发起方
UCB Pharma
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验